Okky Dwichandra Putra
Okky Dwichandra Putra
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Drug–drug multicomponent crystals as an effective technique to overcome weaknesses in parent drugs
OD Putra, T Furuishi, E Yonemochi, K Terada, H Uekusa
Crystal Growth & Design 16 (7), 3577-3581, 2016
Solubility improvement of epalrestat by layered structure formation via cocrystallization
OD Putra, D Umeda, YP Nugraha, T Furuishi, H Nagase, K Fukuzawa, ...
CrystEngComm 19 (19), 2614-2622, 2017
Isostructural multicomponent gliclazide crystals with improved solubility
O Dwichandra Putra, E Yonemochi, H Uekusa
Crystal Growth & Design 16 (11), 6568-6573, 2016
Crystal structure determination of dimenhydrinate after more than 60 years: solving salt–cocrystal ambiguity via solid-state characterizations and solubility study
OD Putra, T Yoshida, D Umeda, K Higashi, H Uekusa, E Yonemochi
Crystal Growth & Design 16 (9), 5223-5229, 2016
Improving mechanical properties of desloratadine via multicomponent crystal formation
A Ainurofiq, R Mauludin, D Mudhakir, D Umeda, SN Soewandhi, OD Putra, ...
European Journal of Pharmaceutical Sciences 111, 65-72, 2018
Simultaneous improvement of epalrestat photostability and solubility via cocrystallization: a case study
OD Putra, D Umeda, YP Nugraha, K Nango, E Yonemochi, H Uekusa
Crystal Growth & Design 18 (1), 373-379, 2018
Solubility improvement of benexate through salt formation using artificial sweetener
O Dwichandra Putra, D Umeda, E Fujita, T Haraguchi, T Uchida, ...
Pharmaceutics 10 (2), 64, 2018
Crystallographic analysis of phase dissociation related to anomalous solubility of irsogladine maleate
OD Putra, T Yoshida, D Umeda, M Gunji, H Uekusa, E Yonemochi
Crystal Growth & Design 16 (12), 6714-6718, 2016
Structural origin of physicochemical properties differences upon dehydration and polymorphic transformation of ciprofloxacin hydrochloride revealed by structure determination …
OD Putra, A Pettersen, E Yonemochi, H Uekusa
CrystEngComm 22 (43), 7272-7279, 2020
Crystal structure of olivetolic acid: a natural product from Cetrelia sanguinea (Schaer.)
ODPHU Friardi Ismed, Aulia Farhan, Amri Bakhtiar, Erizal Zaini, Yuda ...
Acta Crystallographica Section E CRYSTALLOGRAPHIC COMMUNICATIONS 72 (11 …, 2016
Pembentukan padatan semi kristalin dan ko-kristal parasetamol
OD Putra, I Nugrahani, S Ibrahim, H Uekusa
Jurnal Matematika dan Sains 17 (2), 83-88, 2012
Theophylline-Na-saccharin single crystal isolation for its structure determination
I Nugrahani, EA Pertiwi, OD Putra
Int. J. Pharm. Sci 7, 15-24, 2015
Capturing a new hydrate polymorph of amodiaquine dihydrochloride dihydrate via heterogeneous crystallisation
OD Putra, A Pettersen, SON Lill, D Umeda, E Yonemochi, YP Nugraha, ...
CrystEngComm 21 (13), 2053-2057, 2019
Pharmaceutical multicomponent crystals: Structure, design, and properties
OD Putra, H Uekusa
Advances in Organic Crystal Chemistry, 153-184, 2020
A peculiar dehydration and solid–solid phase transition of the active pharmaceutical ingredient AZD9898 based on in situ single crystal-to-single crystal transformations
A Pettersen, OD Putra, ME Light, Y Namatame
CrystEngComm 22 (43), 7280-7289, 2020
Ethyl haematommate from Stereocaulon graminosum Schaer.: isolation and crystal structure
F Ismed, N Arifa, A Bakhtiar, D Umeda, OD Putra, E Yonemochi, E Zaini
Natural Product Sciences 24 (2), 115-118, 2018
Epalrestat tetrahydrofuran monosolvate: crystal structure and phase transition
D Umeda, OD Putra, M Gunji, K Fukuzawa, E Yonemochi
Acta Crystallographica Section E: Crystallographic Communications 73 (7 …, 2017
A new solvate of epalerstat, a drug for diabetic neuropathy
OD Putra, D Umeda, K Fukuzawa, M Gunji, E Yonemochi
Acta Crystallographica Section E: Crystallographic Communications 73 (8 …, 2017
Crystal Structures of Antiarrhythmic drug Disopyramide and its Salt with Phthalic acid
MI Tamboli, Y Okamoto, Y Utsumi, T Furuishi, S Wang, D Umeda, ...
Crystals 11 (4), 379, 2021
Process Development, Manufacture, and Understanding of the Atropisomerism and Polymorphism of Verinurad
Org. Process Res. Dev., 2021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20